TobaccoReporter logo

Tag: report

  • Report Outlines the Mozambique Tobacco Industry

    Report Outlines the Mozambique Tobacco Industry

    ResearchAndMarkets.com has released a report on the tobacco industry in Mozambique, including information on production, manufacture and retail, key trends and issues, notable players, trade, and regulations. “Tobacco Industry in Mozambique” also provides information on major influencing factors such as the security situation, economic environment health, environmental issues, and illegal trading. The report includes company profiles of three players including British American Tobacco, Mozambique Leaf Tobacco, and Afro Tobacco Company.

    For marketing trends, it reports on:

    • An increase in tobacco sales revenues
    • Growth in tobacco exports
    • The concession system provides smallholder farmers with a market to sell their tobacco
    • The introduction of seal stamps on tobacco products, to reduce illicit cigarettes
    • The potential for increased tobacco production
  • Study: E-Cigs Have No Significant Impact on Lung Function

    Study: E-Cigs Have No Significant Impact on Lung Function

    A newly published critical umbrella review in Tobacco Use Insights found that there were no statistically significant changes in respiratory function for e-cigarette (EC) users. Conducted by researchers from the Center of Excellence for the Acceleration of Harm Reduction (CoEHAR), the study highlights the absence of significant short- or medium-term respiratory changes associated with e-cigarette use, regardless of usage patterns.

    Led by Giusy Rita Maria La Rosa, Riccardo Polosa, and Renée O’Leary, the review analyzed 12 systematic reviews on e-cigarette effects, categorizing users into three groups: dual users (who smoke and vape), exclusive users (former smokers who switched to vaping), and naïve users (those who have never smoked but use e-cigarettes).

    “Studies on the latest products on the market have shown reductions in chemical emissions,” said O’Leary. “Across all user categories, there were no statistically significant changes in respiratory function. The five systematic reviews in our analysis concluded that there is no definitive evidence of harm or benefit regardless of the pattern of EC use”

    “Current data do not show significant respiratory variations associated with e-cigarette use in the short or medium term,” La Rosa added. “However, due to the lack of adequate longitudinal studies, no definitive conclusions can be drawn.”

    The researchers said their results, which vary from many others around the industry, can be explained by considering several important factors: acute studies provide data on short-term exposure to e-cigarettes and cannot be used to assess long-term effects; studies do not always account for participants’ smoking history; and individuals with low-frequency e-cigarette use are often grouped together with those who use e-cigarettes more frequently.

    Regarding the quality of the included studies, only five out of 12 reviews were rated as having high or moderate confidence in their findings. Reporting issues were common.

     “The study highlights the importance of distinguishing between different vaping behaviors in future research, as well as addressing methodological weaknesses and biases observed in many previous studies on the topic,” Polosa said. “But it allows us to state once again that vaping cannot be associated to significant changes in respiratory function.”

  • Study: Menthol Cigarettes Linked to Higher Death Risk

    Study: Menthol Cigarettes Linked to Higher Death Risk

    A study recently published in Tobacco Control journal says menthol cigarette smokers had a higher risk of dying from any health cause compared to non-menthol cigarette smokers, in what the researchers claim is the largest and most comprehensive study of its kind.

    The report said, among former smokers, those who smoked menthol cigarettes showed:

    • 12% higher risk of death from all causes
    • 16% higher risk from cardiovascular diseases
    • 13% higher risk from coronary artery disease
    •  43% higher risk from other heart diseases

    “Mortality risks were shown to be especially high for individuals who quit smoking or smoked 40 or more menthol cigarettes per day,” the study said. “In addition, Black Americans who currently smoke menthol cigarettes face an 88% elevated risk of mortality from some heart diseases compared to those smoking non-menthol cigarettes.”

    While smoking rates have declined overall, the study said menthol cigarettes continue to rise in popularity with Blacks, women, and youth. “Menthol cigarettes represented 36% of the market among major manufacturers in 2022—the highest percentage since reporting began in 1963.” The popularity of menthol extends beyond cigarettes, with vape and flavored nicotine pouches also available.

    For the report, researchers followed nearly a million people from the Cancer Prevention Study II, tracking their health over six years. Of the participants, 73,486 smoked menthol cigarettes and 281,680 smoked non-menthol cigarettes. In that time, 4,071 menthol smokers and 20,738 non-menthol smokers died.